Cinepazet

This classification denotes a vasodilating agent with the molecular formula C20H28N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0LC95WWE9Q, chemically known as 4-(1- oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-1-piperazineacetic acid, ethyl ester but generally known as cinepazet, which bears US NIH Compound Identifier 6436156. European Medicines Agency schedules Cinepazet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06291MIG. The term CINEPAZET is an International Non-Proprietary Name. World Health Organization schedules cinepazet in its Anatomical Therapeutic Chemical (ATC) Classification. CINEPAZET is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinepazet under HS 29335995 and SITC 51576. As of Q4 2014, CINEPAZET remains the US FDA Preferred Term for this commodity. Cinepazet bears US NLM identifiers UMLS ID C0055739 and NCI Concept Code C87281. SMILES: O(C(=O)CN1CCN(CC1)C(=O)/C=C\c1cc(OC)c(OC)c(OC)c1)CC.